Secondary Schizophrenia

Secondary Schizophrenia
-0 %
Besorgungstitel - wird vorgemerkt | Lieferzeit: Besorgungstitel - Lieferbar innerhalb von 10 Werktagen I

Unser bisheriger Preis:ORGPRICE: 113,50 €

Jetzt 113,49 €*

Alle Preise inkl. MwSt. | Versandkostenfrei
Artikel-Nr:
9780521856973
Veröffentl:
2010
Erscheinungsdatum:
04.02.2010
Seiten:
450
Autor:
Perminder S Sachdev
Gewicht:
1103 g
Format:
251x192x27 mm
Sprache:
Englisch
Beschreibung:

Perminder S. Sachdev is Scientia Professor of Neuropsychiatry at the School of Psychiatry, University of New South Wales, and Clinical Director of the Neuropsychiatric Institute (NPI), the Prince of Wales Hospital, Sydney, Australia. Matcheri S. Keshavan is Vice Chair of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massaachusetts, USA.
This book is the first major attempt to review the diseases that produce schizophrenia-like syndromes, or psychotic symptoms.
Part I. Introduction: 1. The neurobiology and aetiology of primary schizophrenia: current status Matcheri S. Keshavan and Ripu D. Jindal; 2. The concept of organicity and its application to schizophrenia Perminder S. Sachdev; 3. Secondary hallucinations Mark Walterfang, Ramon Mocellin, David Copolov and Dennis Velakoulis; Part II. The Neurology of Schizophrenia: 4. The neurologic examination in schizophrenia Richard D. Sanders and Matcheri S. Keshavan; 5. Functional neuroimaging in schizophrenia Serge A. Mitelman, Jane Zhang and Monte S. Buchsbaum; Part III. Organic Syndromes of Schizophrenia; Section 1. Epilepsy and Schizophrenia: 6. Schizophrenia-like psychosis and epilepsy Perminder S. Sachdev; 7. Understanding the pathophysiology of schizophrenia through the looking glass of forced normalization Ennapadam S. Krishnamoorthy and Seethalakshmi Ramanathan; Section 2. Drugs and Schizophrenia-like Psychosis: 8. Substance-induced psychosis: an overview Jagadisha Thirthalli, Vivek Benegal and Bangalore N. Gangadhar; 9. Stimulants and psychosis Nash N. Boutros, Matt Galloway and Eric M. Pihlgren; 10. The psychotomimetic effects of PCP, LSD and Ecstasy: pharmacological models of schizophrenia? Vibeke S. Catts and Stanley V. Catts; 11. Schizophrenia secondary to cannabis use Wayne Hall and Louisa Degenhardt; 12. Toxic psychosis Rajeev Kumar and Jeffrey C. L. Looi; Section 3. Other Neurological Disorders: 13. Schizophrenia-like psychosis and traumatic brain injury (TBI) Perminder S. Sachdev; 14. Cerebrovascular disease and psychosis Osvaldo P. Almeida and Sergio E. Starkstein; 15. Neurodegenerative disorders (Alzheimer's disease, frontotemporal dementia) and schizophrenia-like psychosis Nicola T. Lautenschlager and Alexander F. Kurz; 16. Storage disorders and psychosis Mark Walterfang and Dennis Velakoulis; 17. Mitochondrial disorders and psychosis Dennis Velakoulis and Mark Walterfang; 18. Psychosis associated with leukodystrophies Patricia I. Rosebush, Rebecca Anglin and Michael Mazurek; 19. Normal pressure hydrocephalus Julian Trollor; 20. Brain tumours Malcolm Hopwood and Lyn-May Lim; 21. Demyelinating disease and psychosis Anthony Feinstein; Section 4. Systemic Disorders: 22. Infection and schizophrenia Alan S. Brown and Ezra S. Susser; Section 5. Genetic Disorders Related to SLP: 23. The status of genetic investigations of schizophrenia Bryan Mowry; 24. Velocardiofacial Syndrome (Chromosome 22q11.2 Deletion Syndrome) as a model of schizophrenia Vandana Shashi and Margaret N. Berry; 25. Psychosis in Prader-Willi Syndrome Stewart L. Einfeld, Sophie Kavanagh, Arabella Smith and Bruce J. Tonge; 26. Friedrich's Ataxia and schizophrenia-type psychosis Perminder S. Sachdev; 27. Wilson's disease Edward C. Lauterbach and Leslie Lester-Burns; 28. Huntington's disease and related disorders and their association with schizophrenia-like psychosis Perminder S. Sachdev; 29. Fahr's disease and psychosis Kim Burns and Henry Brodaty; Part IV. Related Concepts: 30. The Charles Bonnet Syndrome William Burke; 31. Acute brief psychosis ¿ an organic syndrome? Anand K. Pandurangi; Part V. Treatment: 32. Drug treatment of secondary schizophrenia Michael D. Jibson and Rajiv Tandon; 33. Non-pharmacological interventions in secondary schizophrenia David J. Kavanagh, Jennifer M. Connolly and Kim T. Mueser.

Kunden Rezensionen

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.